Omega Healthcare Investors (OHI) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
30 Jul, 2026Executive summary
Net income for Q2 2026 was $380 million ($1.19 per diluted share), up from $140 million ($0.46 per share) in Q2 2025, driven by strong investment activity and asset sales, with six-month net income at $538.2 million, up from $252.5 million year-over-year.
Revenues for Q2 2026 were $328 million, a 16% increase year-over-year, driven by rental income, interest income, and new operating segment contributions.
Leadership transition as CEO and CFO host their final call, with new appointments and related compensation expenses, highlighting 25 years of industry evolution and a strategic shift to a diversified portfolio.
The company operates two segments: Triple-Net and Operating, with the latter established in 2026 to manage RIDEA-structured senior housing and U.K. care homes.
Emphasis on proactive portfolio management, capital allocation, and a strong, diverse leadership team positioned for future growth.
Financial highlights
Q2 2026 revenue was $328 million, up from $283 million in Q2 2025, with rental income at $266.5 million and interest income at $46.8 million.
Net income available to common shareholders was $380 million ($1.19/share), up from $140 million ($0.46/share) in Q2 2025, primarily due to a $246.5 million gain on asset sales.
Adjusted FFO was $261 million ($0.83/share), and FAD was $248 million ($0.78/share); AFFO increased slightly sequentially.
Nareit FFO for Q2 2026 was $224 million ($0.71/share), up from $213 million ($0.70/share) in Q2 2025.
$700 million in proceeds from asset sales and loan repayments used to pay down revolver, reducing leverage to 3.3x and fixed charge coverage to 6.5x.
Outlook and guidance
Full-year 2026 Adjusted FFO guidance raised to $3.22–$3.26/share, midpoint up $0.02 from prior guidance.
Temporary earnings headwinds expected in Q3 due to timing of asset sales and investment pipeline weighted to late Q3/Q4, but strong growth anticipated in Q4 and 2027.
Guidance includes scheduled loan repayments and assumes $15–$25 million per quarter in asset sales, with continued rent payments from key operators and stable G&A expenses.
Excludes impact from unannounced acquisitions, capital markets activity, or credit loss provisions.
Management anticipates sufficient liquidity to fund operations and dividends over the next twelve months.
Latest events from Omega Healthcare Investors
- High-yield, diversified SNF REIT with strong growth, stable returns, and robust ESG focus.OHI
Investor presentation24 Jul 2026 - Q3 2025 saw higher earnings, raised AFFO guidance, and expanded investment activity.OHI
Q3 20259 Jul 2026 - Strong 2025 results, major investments, and robust 2026 AFFO outlook support continued growth.OHI
Q4 20259 Jul 2026 - Q4 saw strong financial growth, low leverage, and a robust U.K.-driven investment pipeline.OHI
Q4 20248 Jul 2026 - Board and auditor approvals, asset sale rationale, and dividend policy updates highlighted.OHI
AGM 202610 Jun 2026 - Largest SNF REIT, strong financials, poised for growth with demographic tailwinds.OHI
Investor presentation3 Jun 2026 - CEO and CFO transitions in 2026 include succession plans, incentives, and consulting agreements.OHI
Proxy filing21 May 2026 - Q1 2026 saw strong earnings growth, higher AFFO, and increased guidance amid robust investment activity.OHI
Q1 202629 Apr 2026 - Proxy details strong 2025 results, performance-based pay, and leadership in ESG and governance.OHI
Proxy filing21 Apr 2026